MINERVINI, ANGELA
 Distribuzione geografica
Continente #
NA - Nord America 2.620
EU - Europa 1.085
AS - Asia 221
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 3.929
Nazione #
US - Stati Uniti d'America 2.619
DE - Germania 469
CN - Cina 178
SE - Svezia 163
GB - Regno Unito 107
RU - Federazione Russa 104
IT - Italia 87
BE - Belgio 57
FI - Finlandia 35
FR - Francia 34
UA - Ucraina 15
VN - Vietnam 15
IN - India 13
IE - Irlanda 7
IQ - Iraq 4
JP - Giappone 2
KR - Corea 2
PL - Polonia 2
RO - Romania 2
TH - Thailandia 2
TR - Turchia 2
AU - Australia 1
BR - Brasile 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
HR - Croazia 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
NA - Namibia 1
NP - Nepal 1
Totale 3.929
Città #
Fairfield 447
Chandler 281
Woodbridge 249
Ashburn 222
Houston 198
Seattle 181
Cambridge 166
Nyköping 142
Wilmington 135
Ann Arbor 111
New York 93
Beijing 71
Brussels 57
Bari 46
Jacksonville 45
Lawrence 38
Roxbury 38
Nanjing 37
Brooklyn 28
Des Moines 23
Redwood City 23
Marseille 18
Nanchang 17
Princeton 16
Dong Ket 15
San Diego 13
Falls Church 11
Hebei 11
Inglewood 9
Paris 9
Boardman 8
London 8
Helsinki 7
Dublin 6
Tianjin 6
Changsha 5
Pune 5
Shenyang 5
Jiaxing 4
Dearborn 3
Erbil 3
Guangzhou 3
Jinan 3
Zhengzhou 3
Bangkok 2
Brindisi 2
Fuzhou 2
Hefei 2
Indiana 2
Kilburn 2
New Delhi 2
Ningbo 2
Padova 2
Prescot 2
Pulsano 2
San Mateo 2
Terni 2
Washington 2
Ashbourne 1
Augusta 1
Avigliano 1
Berlin 1
Birmingham 1
Brno 1
Bucharest 1
Böblingen 1
Corato 1
Daejeon 1
Duncan 1
Hamburg 1
Hounslow 1
Istanbul 1
Kraków 1
Leawood 1
Mashhad 1
Melbourne 1
Monterrey 1
Norwalk 1
Omsk 1
Perugia 1
Piano Di Sorrento 1
Quzhou 1
San Giovanni in Persiceto 1
Secunderabad 1
Seoul 1
Tappahannock 1
Tokyo 1
Torino 1
Torregrotta 1
Warsaw 1
Wuhan 1
Xian 1
Zagreb 1
Zhoushan 1
Totale 2.883
Nome #
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia. 157
Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia. 157
BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR 151
MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32) 132
Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3 132
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing 127
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia 121
5'RUNX1-3'USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications. 118
Lymphoid Enhancer Binding Factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. 117
Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia 116
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia 116
Decreased TET2 gene expression during chronic myeloid leukemia progression 115
null 115
Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P. 114
BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation? 109
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia 108
RARA and RARG Gene Downregulation Associated with EZH2 Mutation in Acute Promyelocytic-Like Morphology Leukemia 100
ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES 99
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house. 98
Genomic BCR-ABL1 breakpoint characterization by a multistrategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients 96
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies 95
SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia. 94
null 93
Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology. 93
A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia 90
Chronic Myeloid Leukemia with Variant t(9;22) Shows Dysregulated Expression of Genes Included in Pivotal Cellular Pathways 89
null 87
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology 87
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia 85
The Behavior of Cytogenetic/Molecular Markers Associated with JAK2 Mutation Status Before and After Primary Myelofibrosis Progression Supports the Hypothesis of the Leukemic Clone's Independence From the JAK2 Mutation 82
A new recurrent chromosomal translocation t(3;11)(q13;q14) in myelodysplastic syndromes associated with overexpression of the ILDR1 gene. 81
null 73
STAT5B GENE DYSREGULATION CORRELATES WITH LEF1 GENE EXPRESSION IN ADULT ACUTE PROMYELOCYTIC LEUKEMIA 69
ABSOLUTE QUANTIFICATION OF THE PRETREATMENT PML-RARA MOLECULAR TRANSCRIPT DEFINES THE RELAPSE RISK IN ACUTE PROMYELOCYTIC LEUKEMIA 69
Droplet Digital PCR Analysis for Diagnosis and Minimal Residual Disease Monitoring in Adult Ph plus Acute Lymphoblastic Leukemia 64
DROPLET DIGITAL PCR ANALYSIS FOR DIAGNOSIS AND MINIMAL RESIDUAL DISEASE MONITORING IN ADULT PH plus ACUTE LYMPHOBLASTIC LEUKEMIA 62
null 57
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele 53
Nanopore targeted sequencing for rapid gene mutations detection in acute myeloid leukemia 49
HMGA proteins in hematological malignancies 30
null 29
A novel t(3;9)(q21.2; p24.3) associated with SMARCA2 and ZNF148 genes rearrangement in myelodysplastic syndrome 27
Centromeric fragment of chromosome 7 in atypical chronic myeloid leukemia with the SET binding protein 1 gene mutation. 25
Monitoring minimal residual disease by ddPCR in acute lymphoblastic leukemia associated with the FGFR1 gene rearrangement 23
Droplet digital PCR assay for quantifying of CALR mutant allelic burden in myeloproliferative neoplasms 18
Systemic Mastocytosis With Associated Chronic Lymphocytic Leukemia: A Matter Of Diseases Or Prognostic Factors 17
IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater? 8
Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event 8
The Role of NLRP3, a Star of Excellence in Myeloproliferative Neoplasms 4
Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA 3
Totale 4.062
Categoria #
all - tutte 12.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.333


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019376 0 0 0 0 0 0 0 0 24 59 142 151
2019/20201.042 131 35 62 104 106 77 84 103 122 101 65 52
2020/2021654 28 101 36 87 52 57 24 100 25 60 37 47
2021/2022337 27 32 6 8 13 34 15 16 24 27 52 83
2022/2023676 67 106 43 50 79 82 6 87 111 7 18 20
2023/2024285 21 43 15 24 37 131 2 12 0 0 0 0
Totale 4.062